Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-Life Use of Filgotinib in Rheumatoid Arthritis: A Retrospective Cohort Study.
Raimondo V, Caminiti M, Olivo D, Gigliotti P, L'Andolina M, Muto P, Pellegrini R, Varcasia G, Bruno C, Massaro L, Pagano Mariano G, Luppino JME, Cirillo M, Caira V, Calabria M, Ciaffi J, Ferri C, Ursini F. Raimondo V, et al. Among authors: caira v. J Clin Med. 2024 Nov 27;13(23):7185. doi: 10.3390/jcm13237185. J Clin Med. 2024. PMID: 39685644 Free PMC article.
Development and internal-external cross-validation of a patient-reported definition for acute calcium pyrophosphate crystal arthritis.
Cipolletta E, Rozza D, Andres M, Ottaviani S, Pascart T, Calvo-Aranda E, Chiarvetto Peralta MV, Muto P, Calabuig I, Gómez-Sabater S, Caño R, Léger B, Pacaud A, Moscioni E, Bruno C, Caira V, Gómez-González C, Rosa JE, Nakafero G, Filippucci E, Abhishek A. Cipolletta E, et al. Among authors: caira v. Rheumatology (Oxford). 2024 Dec 14:keae681. doi: 10.1093/rheumatology/keae681. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39673792
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase.
Ferri C, Raimondo V, Giuggioli D, Gragnani L, Lorini S, Dagna L, Bosello SL, Foti R, Riccieri V, Guiducci S, Cuomo G, Tavoni A, De Angelis R, Cacciapaglia F, Zanatta E, Cozzi F, Murdaca G, Cavazzana I, Romeo N, Codullo V, Pellegrini R, Varcasia G, De Santis M, Selmi C, Abignano G, Caminiti M, L'Andolina M, Olivo D, Lubrano E, Spinella A, Lumetti F, De Luca G, Ruscitti P, Urraro T, Visentini M, Bellando-Randone S, Visalli E, Testa D, Sciascia G, Masini F, Pellegrino G, Saccon F, Balestri E, Elia G, Ferrari SM, Tonutti A, Dall'Ara F, Pagano Mariano G, Pettiti G, Zanframundo G, Brittelli R, Aiello V, Dal Bosco Y, Foti R, Di Cola I, Scorpiniti D, Fusaro E, Ferrari T, Gigliotti P, Campochiaro C, Francioso F, Iandoli C, Caira V, Zignego AL, D'Angelo S, Franceschini F, Matucci-Cerinic M, Giacomelli R, Doria A, Santini SA, Fallahi P, Iannone F, Antonelli A; COVID-19 & ASD Italian Study Group. Ferri C, et al. Among authors: caira v. J Transl Autoimmun. 2023 Oct 9;7:100212. doi: 10.1016/j.jtauto.2023.100212. eCollection 2023 Dec. J Transl Autoimmun. 2023. PMID: 37854035 Free PMC article.
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group.
Ursini F, Ruscitti P, Addimanda O, Foti R, Raimondo V, Murdaca G, Caira V, Pigatto E, Cuomo G, Lo Gullo A, Cavazzana I, Campochiaro C, Naclerio C, De Angelis R, Ciaffi J, Mancarella L, Brusi V, Marchetti E, Motta F, Visentini M, Lorusso S, De Santis M, De Luca G, Massaro L, Olivo D, Pellegrini R, Francioso F, Luppino J, Di Cola I, Foti R, Varcasia G, Caso F, Reta M, Dagna L, Selmi C, Iagnocco A, Giacomelli R, Iannone F, Ferri C. Ursini F, et al. Among authors: caira v. RMD Open. 2023 Jun;9(2):e003022. doi: 10.1136/rmdopen-2023-003022. RMD Open. 2023. PMID: 37328292 Free PMC article.